Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that predisposes affected individuals to an elevated risk of cardiovascular disease (CVD). The intricate interplay of traditional ...

GC012F pioneers the use of CD19/BCMA dual-targeting CAR-T in SLE, aiming for deeper and wider depletion of autoantibodies producing B-cells and plasma cells SLE is a chronic autoimmune disease, in ...

Lupus affects different people in different ways, and skin problems like rashes or sores are common. In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for ...

Upper Limb Dysfunction Linked to Poor Quality of Life in SLE In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to ...

In patients with systemic lupus erythematosus, impaired upper limb function and difficulty performing daily activities are linked to various quality-of-life domains.

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...

Because lupus is a chronic autoimmune disease that affects several organ systems, routine laboratory test measures are often abnormal. A new study looked to understand the relationship between certain ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), showed efficacy in adults with active systemic lupus erythematosus (SLE) ...

(RTTNews) - Adicet Bio, Inc. (ACET), a clinical stage biotechnology company, Wednesday said it received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for ADI-001 for the ...

The market opportunities for SLE and LN lie in developing targeted therapies, guided by an understanding of epidemiological trends across major markets. Focus on age, sex, and severity can enhance ...

Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with ...